RecruitingPhase 1NCT06817590
Nucleoside Therapy in Patients With Telomere Biology Disorders
Studying Dyskeratosis congenita
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Suneet Agarwal
- Principal Investigator
- Helen Reed, MD, MPH, M.D., M.P.HBoston Children's Hospital
- Intervention
- deoxycytidine(drug)
- Enrollment
- 36 enrolled
- Eligibility
- 1-70 years · All sexes
- Timeline
- 2025 – 2029
Study locations (1)
- Boston Childrens Hospital, Boston, Massachusetts, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06817590 on ClinicalTrials.govOther trials for Dyskeratosis congenita
Additional recruiting or active studies for the same condition.